Cantón R, Novais A, Valverde A, et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008; 14(Suppl. 1): 144-53. [CrossRef] 2. Azap ÖK, Arslan H, Şerefhanoğlu K, et al. Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010; 16(2): 147-51. [CrossRef] 3. Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008; 62(2):284-8. [CrossRef] 4. Tükenmez-Tigen E, Mülazımoğlu L. Toplum kökenli infeksiyonlarda genişlemiş spektrumlu β-laktamazlar ve klinik önemi. Klimik Derg. 2012; 25(3):94-8. 5. Yılmaz E, Akalın H, Özbey S, et al. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Chemother. 2008; 20(5): 581-5. [CrossRef]